Black Swift Group’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Black Swift Group’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-89,016	Closed	-$7.41M	–	116
2023 Q2	$7.41M	Buy	89,016 +67,980	+323%	+$5.69M	2.52%	9
2023 Q1	$1.61M	Buy	+21,036	New	+$1.75M	0.56%	41
2019 Q3	–	Sell	-31,573	Closed	-$2.77M	–	78
2019 Q2	$2.77M	Buy	31,573 +21,873	+225%	+$1.87M	3.63%	10
2019 Q1	$878K	Buy	+9,700	New	+$825K	1.23%	17
2018 Q4	–	Sell	-109,932	Closed	-$10.5M	–	97
2018 Q3	$10.5M	Buy	109,932 +33,563	+44%	+$3.25M	6.81%	4
2018 Q2	$7.27M	Sell	76,369 -44,354	-37%	-$4.08M	3.3%	6
2018 Q1	$10.6M	Buy	120,723 +3,445	+3%	+$315K	7.64%	5
2017 Q4	$9.95M	Buy	117,278 +15,191	+15%	+$1.27M	9.26%	3
2017 Q3	$8.84M	Buy	102,087 +55,065	+117%	+$4.41M	9.17%	3
2017 Q2	$3.63M	Buy	+47,022	New	+$3.34M	1.98%	9

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Black Swift Group's XBI Position: Q3 2023 in Review

Black Swift Group sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 89,016 shares — an estimated $7.41M sold.

Black Swift Group first reported a position in XBI in Q2 2017 and held it in 10 quarters. The position peaked at $10.6M in Q1 2018. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Black Swift Group reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Black Swift Group sold 89,016 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $7.41M.
Black Swift Group first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and held it in 10 quarters.
Black Swift Group's State Street SPDR S&P Biotech ETF position peaked at $10.6M in Q1 2018.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Black Swift Group's 13F filing for Q3 2023, filed 6 Nov 2023.